Ftse Mib
33.315,86
1,24%
DAX
18.131,97
0,32%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
64.884,80
-2,41%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vallon Pharmaceuticals Inc (VLON) Vallon Pharmaceuticals Inc (VLON) Notizie

Vallon Pharmaceuticals Inc

VLON
0,40
0,00 (0,00%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/6/202422:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/6/202422:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/6/202422:48EDGAR2Form 8-K - Current report
14/6/202414:08EDGAR2Form 8-K - Current report
07/6/202422:06EDGAR2Form 8-K - Current report
31/5/202421:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/5/202421:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/5/202422:45EDGAR2Form 8-K - Current report
20/5/202422:13EDGAR2Form 8-K - Current report
20/5/202422:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/5/202422:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202422:44EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/5/202414:02EDGAR2Form 8-K - Current report
10/5/202423:24EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202422:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:31EDGAR2Form DEF 14A - Other definitive proxy statements
01/4/202415:13EDGAR2Form 8-K - Current report
28/3/202421:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/3/202421:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/202422:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/202422:23EDGAR2Form 8-K - Current report
02/2/202422:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/1/202414:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/1/202414:12EDGAR2Form 8-K - Current report
19/1/202422:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/1/202422:15EDGAR2Form 8-K - Current report
16/1/202414:45EDGAR2Form 8-K - Current report
20/12/202323:12EDGAR2Form PRE 14A - Other preliminary proxy statements
15/12/202323:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/12/202315:07EDGAR2Form 8-K - Current report
27/11/202314:38EDGAR2Form 8-K - Current report
24/11/202322:04EDGAR2Form 8-K - Current report
15/11/202314:07EDGAR2Form 8-K - Current report
01/11/202313:45EDGAR2Form 8-K - Current report
13/10/202322:40EDGAR2Form S-3 - Registration statement under Securities Act of..
25/8/202322:42EDGAR2Form 8-K - Current report
23/8/202315:07EDGAR2Form 8-K - Current report
14/8/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202314:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:06EDGAR2Form 8-K - Current report
07/7/202322:03EDGAR2Form 8-K - Current report
06/7/202322:28EDGAR2Form 8-K/A - Current report: [Amend]
Apertura: Min: Max:
Chiusura: 0,40

La tua Cronologia

NASDAQ
VLON
Vallon Pharmaceuticals
BIT
P14P19
BNP Paribas Issuance
USOTC
SYNSY
Syensqo (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network